1060 related articles for article (PubMed ID: 32434518)
1. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
[TBL] [Abstract][Full Text] [Related]
2. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
[TBL] [Abstract][Full Text] [Related]
4. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
Wang X; Li X; Shang Y; Wang J; Zhang X; Su D; Zhao S; Wang Q; Liu L; Li Y; Chen H
Epidemiol Infect; 2020 Sep; 148():e211. PubMed ID: 32900409
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
6. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis.
Li X; Liu C; Mao Z; Xiao M; Wang L; Qi S; Zhou F
Crit Care; 2020 Nov; 24(1):647. PubMed ID: 33198786
[TBL] [Abstract][Full Text] [Related]
7. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
[TBL] [Abstract][Full Text] [Related]
8. [Neutrophil to lymphocyte ratio as a prognostic marker in COVID-19].
Basbus L; Lapidus MI; Martingano I; Puga MC; Pollán J
Medicina (B Aires); 2020; 80 Suppl 3():31-36. PubMed ID: 32658845
[TBL] [Abstract][Full Text] [Related]
9. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19.
Kong M; Zhang H; Cao X; Mao X; Lu Z
Epidemiol Infect; 2020 Jul; 148():e139. PubMed ID: 32641174
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.
Yang AP; Liu JP; Tao WQ; Li HM
Int Immunopharmacol; 2020 Jul; 84():106504. PubMed ID: 32304994
[TBL] [Abstract][Full Text] [Related]
11. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
12. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
[TBL] [Abstract][Full Text] [Related]
13. High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study.
Lian J; Jin C; Hao S; Zhang X; Yang M; Jin X; Lu Y; Hu J; Zhang S; Zheng L; Jia H; Cai H; Zhang Y; Yu G; Wang X; Gu J; Ye C; Yu X; Gao J; Yang Y; Sheng J
Aging (Albany NY); 2020 Jul; 12(14):13849-13859. PubMed ID: 32730223
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.
Liu Y; Du X; Chen J; Jin Y; Peng L; Wang HHX; Luo M; Chen L; Zhao Y
J Infect; 2020 Jul; 81(1):e6-e12. PubMed ID: 32283162
[TBL] [Abstract][Full Text] [Related]
15. [Biochemical analysis between common type and critical type of COVID-19 and clinical value of neutrophil/lymphocyte ratio].
Li H; Zhao M; Xu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):965-971. PubMed ID: 32895161
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.
Peng J; Qi D; Yuan G; Deng X; Mei Y; Feng L; Wang D
J Clin Lab Anal; 2020 Oct; 34(10):e23475. PubMed ID: 32681559
[TBL] [Abstract][Full Text] [Related]
17. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
18. A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.
Gong J; Ou J; Qiu X; Jie Y; Chen Y; Yuan L; Cao J; Tan M; Xu W; Zheng F; Shi Y; Hu B
Clin Infect Dis; 2020 Jul; 71(15):833-840. PubMed ID: 32296824
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 and severity of COVID-19 patients in Hefei, China.
Zhao Z; Xie J; Yin M; Yang Y; Ding C; Gao Y; Ma X
Med Mal Infect; 2020 Oct; 50(7):629-631. PubMed ID: 32593746
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
